TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 255 filers reported holding TG THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $43,957 | -55.2% | 5,258 | +33.2% | 0.02% | -54.2% |
| Q2 2023 | $98,019 | +46.6% | 3,946 | -11.2% | 0.05% | +33.3% |
| Q1 2023 | $66,868 | +32.3% | 4,446 | +4.1% | 0.04% | +24.1% |
| Q4 2022 | $50,538 | +53.1% | 4,272 | -24.2% | 0.03% | +52.6% |
| Q3 2022 | $33,000 | +65.0% | 5,634 | +20.6% | 0.02% | +58.3% |
| Q2 2022 | $20,000 | -58.3% | 4,672 | -7.5% | 0.01% | -50.0% |
| Q1 2022 | $48,000 | -50.0% | 5,052 | 0.0% | 0.02% | -46.7% |
| Q4 2021 | $96,000 | -45.1% | 5,052 | -3.7% | 0.04% | -58.7% |
| Q3 2021 | $175,000 | -19.7% | 5,244 | -6.7% | 0.11% | -18.7% |
| Q2 2021 | $218,000 | -22.1% | 5,622 | -3.3% | 0.13% | -35.0% |
| Q1 2021 | $280,000 | +976.9% | 5,815 | +1042.4% | 0.21% | +881.0% |
| Q4 2020 | $26,000 | – | 509 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,198,337 | $33,613,000 | 1.96% |
| GREAT POINT PARTNERS LLC | 3,000,000 | $12,300,000 | 1.56% |
| BRIDGER MANAGEMENT, LLC | 3,791,531 | $15,545,000 | 1.30% |
| Avoro Capital Advisors LLC | 4,750,000 | $19,475,000 | 1.16% |
| Opaleye Management Inc. | 550,000 | $2,255,000 | 0.84% |
| CREDIT AGRICOLE S A | 1,307,428 | $5,360,000 | 0.30% |
| Eversept Partners, LP | 65,000 | $266,500 | 0.14% |
| HIGHLAND CAPITAL MANAGEMENT LP | 453,360 | $1,859,000 | 0.14% |
| 683 Capital Management, LLC | 500,000 | $2,050,000 | 0.12% |
| Artal Group S.A. | 400,000 | $1,640,000 | 0.06% |